PRISMASOL BGK2/3.5 5.4 g/L (Calcium Chloride, Magnesium Chloride, Dextrose Anhydrous, Lactic Acid, Sodium Chloride, Sodium Bicar INJECTION) 5.4 g/L

PRISMASOL BGK2/3.5 5.4 g/L is an intravenous injection containing calcium chloride, magnesium chloride, dextrose anhydrous, lactic acid, sodium chloride, and sodium bicarbonate. It is designed to support electrolyte balance and fluid replacement in clinical settings. This product is manufactured by Vantive US Healthcare LLC.

Strength

5.4 g/L

Pack Size

2 BAG in 1 CASE (24571-103-06) / 5 L in 1 BAG

Manufacturer / TM Owner

Vantive US Healthcare LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

PRISMASOL BGK2/3.5 5.4 g/L is used to replenish essential electrolytes and fluids in the body. It is commonly administered to patients who require intravenous fluid therapy to maintain proper hydration and electrolyte levels. This solution is particularly useful in situations where oral intake is not feasible or sufficient.

Side Effects

The effects of PRISMASOL BGK2/3.5 5.4 g/L include the restoration of electrolyte balance and hydration. Patients may experience improved energy levels and overall well-being as the solution helps to maintain the body's fluid and electrolyte equilibrium. Common effects include a sense of rehydration and stabilization of vital electrolytes.

Precautions & Warnings

PRISMASOL BGK2/3.5 5.4 g/L should be administered under medical supervision. It is important to follow the prescribed dosage and administration guidelines to avoid potential side effects. Patients with certain medical conditions or allergies should consult their healthcare provider before use.

Avoid Interactions

PRISMASOL BGK2/3.5 5.4 g/L may interact with other medications or substances. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain dietary supplements may also affect the efficacy of this solution.

Frequently Asked Questions

PRISMASOL BGK2/3.5 5.4 g/L is used to replenish essential electrolytes and fluids in the body, supporting hydration and electrolyte balance.

PRISMASOL BGK2/3.5 5.4 g/L is administered intravenously under medical supervision.

Common effects include improved hydration and stabilization of vital electrolytes, leading to a sense of well-being.

Yes, it should be administered under medical supervision, and patients with certain medical conditions or allergies should consult their healthcare provider.

Yes, it may interact with other medications or substances, so it is important to inform your healthcare provider about all medications you are taking.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.